Recent books by critics of the pharmaceutical industry (such as David Healy's Pharmageddon and Ben Goldacre's Bad Pharma) have highlighted problems in the way the industry promotes its products.
In a 2010 article in Bioethical Enquiry, Spielmans and Parry argue the following (this is from their abstract):
While much excitement has been generated surrounding evidence-based medicine, internal docu- ments from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.
Is their summary of the current situation correct? Is prescribing dominated by marketing not evidence?